All In Biotech

Drug Trial Radar · NCT03533257

Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease

Phase II Study to Assess the Safety, Tolerability, and Target Engagement of AMX0035, a Fixed Combination of Sodium Phenylbutyrate and Tauroursodeoxycholic Acid for the Treatment of Alzheimer's Disease

Last checked: Nov 19, 2026Latest source record: Mar 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

95

Actual

Start

Sep 14, 2018

Primary completion

Oct 22, 2020

Study completion Nov 6, 2020

Sponsor

Lead sponsor
Amylyx Pharmaceuticals Inc.Industry
Sponsor type
Industry
Collaborators
Alzheimer's Drug Discovery Foundation; Alzheimer's Association
First posted
May 23, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 55 years, up to 89 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study is a 24-week, randomized, double-blind, multi-site, placebo-controlled study in participants with mild cognitive impairment (MCI) or early dementia due to Alzheimer's disease (AD).

Conditions

  • Alzheimer Disease

Interventions

  • AMX0035Drug

    Combination Therapy of PB and TURSO

  • PlaceboDrug

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Treatment-Emergent Adverse Event (TEAEs)Time frame: From first dose to 24 weeks
  2. Effect of Treatment on a Global Composite Statistical Test of Cognition, Function, and Neuroanatomy (GST)Time frame: 24 weeks

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Clinical Neuroscience Solutions, Inc. - Jacksonville

    Jacksonville, Florida

  • Clinical Neuroscience Solutions, Inc. - Orlando

    Orlando, Florida

  • International Medical Investigational Centers (IMIC)

    Palmetto Bay, Florida

  • Rush University Medical Center

    Chicago, Illinois

  • University of Kansas Clinical Research Center

    Fairway, Kansas

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Rowan University School of Osteopathic Medicine

    Stratford, New Jersey

  • Mount Sinai Alzheimer's Disease Research Center

    New York, New York

  • Columbia University

    New York, New York

  • Hospital of the University of Pennsylvania, Penn Memory Center

    Philadelphia, Pennsylvania

  • Genesis NeuroScience Clinic

    Knoxville, Tennessee

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.